CD8A and cancer: Cancer cells of the EMT meta program exhibited abundant ligand receptor pairs with endothelial cells, fibroblasts, proliferative CD8+ T cells, dendritic cells and mesangial cells (Figure 7A), and there were more interactions with such cell types when compared with other meta programs (Figure 7B).